Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
03
04
2022
accepted:
01
08
2022
revised:
22
07
2022
pubmed:
24
8
2022
medline:
25
11
2022
entrez:
23
8
2022
Statut:
ppublish
Résumé
Cigarette smoking is the main risk factor for head and neck cancer (HNC) and many HNC patients are active smokers at diagnosis. We conducted a systematic literature review and meta-analysis to quantify the survival impact of smoking cessation at or around the time of HNC diagnosis. We searched studies published until December 31, 2021, and used random-effects meta-analysis to pool study-specific estimates into summary hazard ratio (SHR) and corresponding 95% confidence intervals (CI). Sixteen studies were published between 1983 and 2021, and over 2300 HNC patients were included. Studies were diverse in terms of design, patients, tumours and treatment characteristics, and criteria used to discriminate quitters from continued smokers. HNC patients who quit smoking at or around diagnosis had significantly better overall survival than continued smokers (SHR 0.80, 95% CI 0.70-0.91, n studies = 10). A beneficial effect of post-diagnosis smoking cessation was suggested for other survival endpoints as well, but the results were based on fewer studies (n = 5) and affected by publication bias. Cessation counselling should be offered to all smokers who start a diagnostic workup for HNC and should be considered standard multidisciplinary oncological care for HNC patients. PROSPERO registration number CRD42021245560.
Identifiants
pubmed: 35999273
doi: 10.1038/s41416-022-01945-w
pii: 10.1038/s41416-022-01945-w
pmc: PMC9681856
doi:
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1907-1915Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6:92.
pubmed: 33243986
doi: 10.1038/s41572-020-00224-3
Chow LQM. Head and neck cancer. Reply. N Engl J Med. 2020;382:e57.
pubmed: 32402180
doi: 10.1056/NEJMra1715715
Menezes FDS, Fernandes GA, Antunes JLF, Villa LL, Toporcov TN. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: a systematic review of population-based studies. Oral Oncol. 2021;115:105177.
pubmed: 33561611
doi: 10.1016/j.oraloncology.2020.105177
Hashim D, Genden E, Posner M, Hashibe M, Boffetta P. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019;30:744–56.
pubmed: 30840052
pmcid: 6551449
doi: 10.1093/annonc/mdz084
Tiwana MS, Wu J, Hay J, Wong F, Cheung W, Olson RA. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province. Oral Oncol. 2014;50:651–6.
pubmed: 24731736
doi: 10.1016/j.oraloncology.2014.03.009
Sitas F, Weber MF, Egger S, Yap S, Chiew M, O’Connell D. Smoking cessation after cancer. J Clin Oncol. 2014;32:3593–5.
pubmed: 25267760
doi: 10.1200/JCO.2014.55.9666
Caini S, Del Riccio M, Vettori V, Scotti V, Martinoli C, Raimondi S, et al. Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2022;17:623–36.
pubmed: 34995798
doi: 10.1016/j.jtho.2021.12.005
Chen JL, Shen CW, Wang CC, Huang YS, Chen JP, Chiang CH, et al. Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: a prospective study. Head Neck. 2019;41:3201–10.
pubmed: 31116482
doi: 10.1002/hed.25814
Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132:401–10.
pubmed: 22539012
doi: 10.1002/ijc.27617
Sandoval M, Font R, Mañós M, Dicenta M, Quintana MJ, Bosch FX, et al. The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain. Int J Oral Maxillofac Surg. 2009;38:31–39.
pubmed: 18951763
doi: 10.1016/j.ijom.2008.09.004
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.
pubmed: 19631508
doi: 10.1016/j.jclinepi.2009.06.005
National Institute for Health Research. PROSPERO International prospective register of systematic reviews. Accessed 28 April 2021. https://www.crd.york.ac.uk/PROSPERO/ .
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.
pubmed: 9921604
doi: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280–6.
pubmed: 23420236
doi: 10.7326/0003-4819-158-4-201302190-00009
Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1–30.
pubmed: 3678409
doi: 10.1093/oxfordjournals.epirev.a036298
Michiels S, Le Maître A, Buyse M, Burzykowski T, Maillard E, Bogaerts J, et al. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol. 2009;10:341–50.
pubmed: 19246242
doi: 10.1016/S1470-2045(09)70023-3
van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21:589–624.
pubmed: 11836738
doi: 10.1002/sim.1040
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
pubmed: 12111919
doi: 10.1002/sim.1186
Cochrane Handbook for Systematic Reviews of Interventions. Chapter 10: Analysing data and undertaking meta-analyses. Accessed 21 December 2021. https://training.cochrane.org/handbook/current/chapter-10 .
Egger M, Davey, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
pubmed: 9310563
pmcid: 2127453
doi: 10.1136/bmj.315.7109.629
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
pubmed: 7786990
doi: 10.2307/2533446
Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.
pubmed: 10877304
doi: 10.1111/j.0006-341X.2000.00455.x
Tatekawa S, Shimamoto S, Miyata Y, Yoshino Y, Hirata T, Tamari K, et al. Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma. Acta Oncol. 2021;60:582–8.
pubmed: 33406970
doi: 10.1080/0284186X.2020.1865563
Day AT, Dahlstrom KR, Lee R, Karam-Hage M, Sturgis EM. Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma. Head Neck. 2020;42:2440–52.
pubmed: 32476217
pmcid: 8691203
doi: 10.1002/hed.26268
Koshiaris C, Aveyard P, Oke J, Ryan R, Szatkowski L, Stevens R, et al. Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study. Br J Cancer. 2017;117:1224–32.
pubmed: 28898236
pmcid: 5674091
doi: 10.1038/bjc.2017.179
Deutschmann MW, Sykes KJ, Harbison J, Cabrera-Muffly C, Shnayder Y. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2015;141:519–25.
pubmed: 25950859
doi: 10.1001/jamaoto.2015.0643
Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, et al. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol. 2013;8:21.
pubmed: 23360540
pmcid: 3576243
doi: 10.1186/1748-717X-8-21
Ritoe SC, Verbeek AL, Krabbe PF, Kaanders JH, van den Hoogen FJ, Marres HA. Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer: definition of a high-risk group and estimation of the lead time. Head Neck. 2007;29:431–8.
pubmed: 17120311
doi: 10.1002/hed.20534
Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck. 2002;24:1031–7.
pubmed: 12454940
doi: 10.1002/hed.10168
Benninger MS, Gillen J, Thieme P, Jacobson B, Dragovich J. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope. 1994;104:294–8.
pubmed: 8127185
doi: 10.1288/00005537-199403000-00009
Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N. Engl J Med. 1993;328:159–63.
pubmed: 8417381
doi: 10.1056/NEJM199301213280302
Stevens MH, Gardner JW, Parkin JL, Johnson LP. Head and neck cancer survival and life-style change. Arch Otolaryngol. 1983;109:746–9.
pubmed: 6639443
doi: 10.1001/archotol.1983.00800250040009
Fazel A, Quabius ES, Gonzales-Donate M, Laudien M, Herzog A, Kress K, et al. Alteration of smoking habit at time of first diagnosis influences survival of patients with HNSCC. Mol Clin Oncol. 2020;13:50.
pubmed: 32874580
pmcid: 7453390
doi: 10.3892/mco.2020.2120
Choi SH, Terrell JE, Bradford CR, Ghanem T, Spector ME, Wolf GT, et al. Does quitting smoking make a difference among newly diagnosed head and neck cancer patients? Nicotine Tob Res. 2016;18:2216–24.
pubmed: 27613928
pmcid: 5103939
doi: 10.1093/ntr/ntw189
Eichler M, Keszte J, Meyer A, Danker H, Guntinas-Lichius O, Oeken J, et al. Tobacco and alcohol consumption after total laryngectomy and survival: a German multicenter prospective cohort study. Head Neck. 2016;38:1324–9.
pubmed: 27043145
doi: 10.1002/hed.24436
Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16:669–83.
pubmed: 31189965
doi: 10.1038/s41571-019-0227-z
Do KA, Johnson MM, Doherty DA, Lee JJ, Wu XF, Dong Q, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003;14:131–8.
pubmed: 12749718
doi: 10.1023/A:1023060315781
Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006;98:441–50.
pubmed: 16595780
doi: 10.1093/jnci/djj091
Meyer F, Bairati I, Fortin A, Gélinas M, Nabid A, Brochet F, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer. 2008;122:1679–83.
pubmed: 18059031
doi: 10.1002/ijc.23200
Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol. 2009;27:1969–75.
pubmed: 19289626
pmcid: 2669762
doi: 10.1200/JCO.2008.18.2188
Smith J, Nastasi D, Tso R, Vangaveti V, Renison B, Chilkuri M. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis. Radiother Oncol. 2019;135:51–57.
pubmed: 31015170
doi: 10.1016/j.radonc.2019.02.021
Chen AM, Chen LM, Vaughan A, Farwell DG, Luu Q, Purdy JA, et al. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy. Am J Clin Oncol. 2011;34:270–5.
pubmed: 20622648
doi: 10.1097/COC.0b013e3181dea40b
Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue oxygen. Arch Surg. 1991;126:1131–4.
pubmed: 1929845
doi: 10.1001/archsurg.1991.01410330093013
Fiorini FR, Deganello A, Larotonda G, Mannelli G, Gallo O. Tobacco exposure and complications in conservative laryngeal surgery. Cancers (Basel). 2014;6:1727–35.
doi: 10.3390/cancers6031727
World Health Organization (WHO). WHO tobacco knowledge summaries: tobacco and postsurgical outcomes. Accessed 28 January 2022. https://apps.who.int/iris/handle/10665/330485 .
de la Iglesia JV, Slebos RJC, Martin-Gomez L, Wang X, Teer JK, Tan AC, et al. Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma. Clin Cancer Res. 2020;26:1474–85.
pubmed: 31848186
doi: 10.1158/1078-0432.CCR-19-1769
Peters SA, Huxley RR, Woodward M. Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study. BMJ Open. 2014;4:e005663.
pubmed: 25550291
pmcid: 4281541
doi: 10.1136/bmjopen-2014-005663
Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex/gender differences in smoking cessation: a review. Prev Med. 2016;92:135–40.
pubmed: 27471021
pmcid: 5085924
doi: 10.1016/j.ypmed.2016.07.013
Mundi N, Ghasemi F, Zeng PYF, Prokopec SD, Patel K, Kim HAJ, et al. Sex disparities in head & neck cancer driver genes: an analysis of the TCGA dataset. Oral Oncol. 2020;104:104614.
pubmed: 32146388
doi: 10.1016/j.oraloncology.2020.104614
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Accessed 5 July 2022. https://gdt.gradepro.org/app/handbook/handbook.html .
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.